Copellor Injection

Introduction

Copellor is a prescription medication that contains the active ingredient Ixekizumab. It is also known by its generic name. This medication is primarily used for the treatment of certain inflammatory conditions.

Uses

Copellor is prescribed to treat various inflammatory conditions, such as psoriasis and psoriatic arthritis. It is specifically used in patients who have not responded well to other treatments or who have severe symptoms that significantly impact their quality of life.

Dosage and Administration

The dosage and administration of Copellor will depend on the specific condition being treated and the patient’s individual needs. It is typically administered by a healthcare professional as an injection under the skin (subcutaneous injection). The exact dosage and frequency will be determined by the prescribing healthcare provider and may vary from patient to patient.

Mechanism of Action

Copellor works by targeting a specific protein in the body called interleukin-17A (IL-17A). IL-17A is involved in the inflammatory process that contributes to conditions like psoriasis and psoriatic arthritis. By blocking IL-17A, this medication helps to reduce inflammation and improve symptoms.

Side Effects

Common side effects may include injection site reactions, such as redness, swelling, or pain. Other possible side effects may include upper respiratory tract infections, headaches, or diarrhea.

In some cases, Copellor may also be associated with more serious side effects. These can include severe allergic reactions, infections, or changes in liver function. Seek medical attention if any severe side effects occur.

Drug Interactions

Copellor may interact with certain medications, including other immunosuppressive drugs. Inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal products, before starting Copellor. They can evaluate any potential drug interactions and adjust your treatment plan as necessary.

Precautions

Before using Copellor, discuss any medical conditions or allergies you have with your healthcare provider. This medication may not be suitable for everyone, especially those with a history of certain infections or immunodeficiency disorders.

Copellor may also interact with other medications, including live vaccines. Inform your healthcare provider if you have recently received or are scheduled to receive any vaccines.

Storage

Copellor should be stored in the refrigerator between 2°C and 8°C (36°F and 46°F). Keep the medication in its original packaging until ready to use. Do not freeze the medication. If you have any questions about storage, consult your healthcare provider or pharmacist.

Patient Tips

• Follow the dosage instructions provided by your healthcare provider. Do not change the dose or frequency without consulting them first.
• If you are administering the injection at home, make sure to carefully follow the instructions provided by your healthcare provider.
• Keep track of any side effects you experience and report them to your healthcare provider. They can help determine if any adjustments to your treatment plan are necessary.
• If you have any questions or concerns about Copellor, don’t hesitate to reach out to your healthcare provider or pharmacist. They are there to support you and provide further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Taltz 80 mg solution for injection in pre-filled pen (Health Professionals SmPC) Available at:
• Ixekizumab (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• ixekizumab auto-injector (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Ixekizumab Injection (MedlinePlus) [Accessed 10 Jun. 2024] (online) Available at:
• Yiu ZZN, Becher G, Kirby B, Laws P, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM; BADBIR Study Group. Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis. JAMA Dermatol. 2022 Oct 1;158(10):1131-1141. doi: 10.1001/jamadermatol.2022.2909. [Accessed 22 Jun. 2024] Available at: